Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
Manufacturers have agreed to provide eligible GLP-1s under the Bridge program at a net price of $245 per month supply
Next steps: Ask a clinician about approved alternatives and monitoring
Adverse Effects and Reporting Adverse events or suspected contamination issues should be reported immediately to the manufacturer (Hospira/Pfizer) and relevant regulatory authorities (FDA MedWatch, poison control, or institutional pharmacovigilance systems)
The nasal spray format contributes to this movement by offering an elegant, repeatable, and efficient way to study how GLP-1 analogs behave in metabolic scenarios
US$ 20.68
US$ 22.74
US$ 27.22
US$ 22.16
US$ 27.08
US$ 24.53
US$ 22.35
